Serious haematological toxicity during and after ipilimumab treatment: a case series

INTRODUCTION: Immunotherapy with the anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody ipilimumab has been shown to improve overall survival in previously treated and treatment-naïve patients with unresectable stage III or IV melanoma. Consistent with its proposed immunomodulating mechanism...

Descripción completa

Detalles Bibliográficos
Autores principales: Simeone, Ester, Grimaldi, Antonio Maria, Esposito, Assunta, Curvietto, Marcello, Palla, Marco, Paone, Miriam, Mozzillo, Nicola, Ascierto, Paolo Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090655/
https://www.ncbi.nlm.nih.gov/pubmed/24986059
http://dx.doi.org/10.1186/1752-1947-8-240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090655/
https://www.ncbi.nlm.nih.gov/pubmed/24986059
http://dx.doi.org/10.1186/1752-1947-8-240

Ejemplares similares